Controlling Diabetes & CHF Costs by Addressing CKD
It is well known that chronic kidney disease (CKD) and end stage renal disease (ESRD) multiply health risks for patients with diabetes and congestive heart failure (CHF). Thus, they consume considerably more healthcare resources than those without these comorbidities. CKD is the only comorbidity that predicts which diabetics are in the top decile of costs — and that top 10% incurs $50,000 greater annual costs than all other diabetics.
Listen as medical researcher and nephrologist Dr. Navdeep Tangri, inventor of the Kidney Failure Risk Equation, discusses how health systems can gain better control of diabetes and CHF costs by addressing CKD.
- How CHF and diabetes accelerate kidney disease, and vice versa
- Why optimal CKD management requires an accurate risk indicator
- How health systems can realize significant savings among these patient populations
Navdeep Tangri, MD, Ph.D., FRCP(C)
Navdeep Tangri is an attending physician and Associate Professor in the Division of Nephrology, Department of Medicine and the Department of Community Health Sciences at the University of Manitoba. Dr. Tangri’s research program is clinical and translational, and focused on improving clinical decision making for patients with advanced chronic kidney disease. He developed and validated the Kidney Failure Risk Equation to predict the need for dialysis in patients with CKD, and is presently engaged in multiple validation and implementation exercises to increase the uptake of the KFRE. In addition, Dr. Tangri is conducting a large prospective study on frailty, physical and cognitive function in advanced CKD, as well as comparative effectiveness studies on the safety and effectiveness of medical therapies in this population. He has published more than 120 manuscripts and presented at multiple national and international scientific meetings. He sits on the editorial board of the American Journal of Kidney Disease, Canadian Journal of Kidney Health and Disease, and is Section Editor for the Epidemiology and Prevention Issue of Current Opinion in Nephrology and Hypertension. He has active grants from the Canadian Institute of Health Research, the Kidney Foundation of Canada, and the Manitoba Health Research Council.